Substance Use Disorder Treatment and Recovery

DynamiCare Motivation Support Program is a digital coaching program that helps monitor and motivate people to achieve healthy goals with drugs, opioids, alcohol, and tobacco. We match members with a telehealth recovery coach who motivates the member on weekly voice/video calls. DynamiCare empowers people to perform substance tests through our app anytime, anywhere, through connected breath and saliva tests verified by selfie video. The app can also track treatment attendance using GPS, creating accountability and encouragement. We lift the burden from providers, placing it into the hands of the client -- improving accountability while increasing dignity. Our program leverages financial rewards to reinforce healthy behavior. The platform automates an evidence-based methodology that has been demonstrated to be effective in over 100 randomized controlled trials.

RapidIdentity is the most complete Identity and Access Management (IAM) platform available, giving organizations greater security, increased business agility, and lower costs of identity and access management. With RapidIdentity, organizations can transform identity and access management across all users—including employees, contractors, partners, and vendors. Improve productivity and collaboration by giving the right people, the right access, from anywhere—for the time needed.

SPOT is a novel Clinician Decision Support Digital Health CE-marked medical device platform. Using AI, SPOT is able to harness information to enable the development of guidelines and predict prescriber performance to ensure safe and effective treatment of pain. SPOT supports prescribers switching patients addicted or misusing opioids to buprenorphine as part of a medication-assisted treatment regime to reduce the risk of opioid overdose death. SPOT is also used in palliative and end of life care settings to support opioid switch in cases of toxicity or unwanted side effects. In a real world, cross setting and multi-professional study in the NHS it is proven to significantly improve the confidence of opioid prescribing in users and adherence to best practice guidelines. SPOT is designed to reduce unwarranted variation and primary and secondary harms when prescribing opioids whilst supporting warranted variation of choice to align to individual situations, values and side effect profiles. SPOT is able to monitor drug usage and spend and suggest lower-cost opioids to users to reduce costs to healthcare organisations. SPOT is currently in use in the NHS.

We rebuilt the diagnostic imaging communication layer from the ground up to enable patients, providers, clinics and hospitals around the world to get to the right answers in seconds